¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦4Â÷ ´ëÇѹé¹ÝÁõ»ö¼ÒÇÐȸ ½ÉÆ÷Áö¾ö : 2024-04-20

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

Á¦4Â÷ ´ëÇѹé¹ÝÁõ»ö¼ÒÇÐȸ ½ÉÆ÷Áö¾ö : 2024-04-20
±³À°ÀÏÀÚ : 2024-04-20
±³À°Àå¼Ò : ¿¬¼¼´ëÇб³ ¿¡ºñ½¼ÀÇ»ý¸í¿¬±¸¼¾ÅÍ 1Ãþ À¯ÀÏÇÑ È¦

±³À°ÁÖÁ¦ : Á¦4Â÷ ´ëÇѹé¹ÝÁõ»ö¼ÒÇÐȸ ½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѹé¹ÝÁõ»ö¼ÒÇÐȸ

´ã´çÀÚ : À¯È­Á¤
¿¬¶ôó : 02-6671-1373

À̸ÞÀÏ : narim2007@narim.co.kr

±³À°Á¾·ù : ÇǺΰú

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 60,000¿ø  

ºñ°í »çÀüµî·Ï: Á¤È¸¿ø(ÇǺΰú Àü¹®ÀÇ) 5¸¸¿ø, ÁØȸ¿ø(ÇǺΰú Àü°øÀÇ) 3¸¸¿ø, ¿¬±¸¿ø 5¸¸¿ø, ºñȸ¿ø 50¸¸¿øÇöÀåµî·Ï: Á¤È¸¿ø(ÇǺΰú Àü¹®ÀÇ) 6¸¸¿ø, ÁØȸ¿ø (ÇǺΰú Àü°øÀÇ) 3¸¸¿ø, ¿¬±¸¿ø 6¸¸¿ø, ºñȸ¿ø 50¸¸¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±âŸ 04¿ù 20ÀÏ 09:30~09:40 Opening addressCongratulatory remarks ()

±³À°½Ã°£ 04¿ù 20ÀÏ 09:40~09:55 The latest breakthroughs in vitiligo research ÃÖÁ¾¿ø(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ 09:55~10:10 The intricacies of melanocyte biology: understanding skin pigmentation ¿À»óÈ£(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ 10:10~10:25 JAK inhibitors in vitiligo ¹èÁ¤¹Î(ÈúÇϿ콺ÇǺΰúÀÇ¿ø)

±³À°½Ã°£ 04¿ù 20ÀÏ 10:25~10:40 Updates in medical therapies other than JAK inhibitors in vitiligo Á¤ÁعÎ(¿ï»êÀÇ´ë)

Åä·Ð 04¿ù 20ÀÏ 10:40~10:50 Q&A ()

±³À°½Ã°£ 04¿ù 20ÀÏ 10:50~10:55 (ÀÚÀ¯¿¬Á¦)Disruption of anchorage between melanocytes and the basement membrane promotes melanocyte detachment in vitiligo ±ÇÀÏÁÖ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ 10:55~11:00 (ÀÚÀ¯¿¬Á¦)Methotrexate for vitiligo ÁÖÇöÁ¤(°¡Å縯ÀÇ´ë)

Åä·Ð 04¿ù 20ÀÏ 11:00~11:05 Q&A ()

ÈÞ½Ä 04¿ù 20ÀÏ 11:05~11:20 Coffee break and poster viewing ()

±³À°½Ã°£ 04¿ù 20ÀÏ 11:20~11:35 Pediatric vitiligo: children are not small adults ±Ç¼øÈ¿(°æÈñÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ 11:35~11:50 Impact of vitiligo on quality of life ÁÖÇöÁ¤(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ 11:50~12:05 Measurement tools for vitiligo and computer-aided evaluation À̼־Ï(¿¬¼¼¿øÁÖÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ 12:05~12:15 Q&A ()

±³À°½Ã°£ 04¿ù 20ÀÏ 12:15~12:20 (ÀÚÀ¯¿¬Á¦)A clinical study on the recurrence of vitiligo ½ÅÁ¤Çö(ÀÎÇÏÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ 12:20~12:25 (ÀÚÀ¯¿¬Á¦)Non-invasive diagnosis of human skin using photoacoustic imaging ÇÑÁÖÈñ(°¡Å縯ÀÇ´ë)

Åä·Ð 04¿ù 20ÀÏ 12:25~12:30 Q&A ()

½Ä»ç 04¿ù 20ÀÏ 12:30~14:00 Lunch & Group photo & General assembly ()

±³À°½Ã°£ 04¿ù 20ÀÏ 14:00~14:40 Immunological memory of vitiligo Julien Seneschal(CHU de Bordeaux)

±³À°½Ã°£ 04¿ù 20ÀÏ 14:40~14:55 Deeper insights into ABNOM Á¤º¸¿µ(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ 14:55~15:10 Updates in Riehl ±è¸í½Å(ÀÎÁ¦ÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ 15:10~15:25 Exosomes in pigmentary disorders À̽ÃÇü(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ 15:25~15:40 Polynucleotides and botulinum toxin in pigmentary disorders ±èÇý¼º(°¡Å縯ÀÇ´ë)

Åä·Ð 04¿ù 20ÀÏ 15:40~15:50 Q&A ()

±³À°½Ã°£ 04¿ù 20ÀÏ 15:50~15:55 (ÀÚÀ¯¿¬Á¦)Evaluation of dermal melanophages in acquired bilateral nevus of ota-like macules ȲÁ¤¹Î(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ 15:55~16:00 (ÀÚÀ¯¿¬Á¦)Exploring the function of IRE1¥á signaling in the skin and its connection to hyperpigmentation and aging Ȳ½Å¿ø(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ 16:00~16:05 (ÀÚÀ¯¿¬Á¦)Differential diagnosis of skin lesions showing agminated pigmented macules based on clinical characteristics and treatment response ÇÑÇýÁ¤(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ 16:05~16:10 (ÀÚÀ¯¿¬Á¦)A collagen biostimulator improves photoaging pigmentation ±èÁøö(¾ÆÁÖÀÇ´ë)

Åä·Ð 04¿ù 20ÀÏ 16:10~16:15 Q&A ()

ÈÞ½Ä 04¿ù 20ÀÏ 16:15~16:30 Coffee break, °ø·ÎÆÐ ÁõÁ¤, »çÁøÃÔ¿µ ()

±³À°½Ã°£ 04¿ù 20ÀÏ 16:30~16:45 Treatment of pigmentary disorders using IPL ±è¹æ¼ø()

±³À°½Ã°£ 04¿ù 20ÀÏ 16:45~17:00 How to use picosecond lasers in pigmentary disorders ¾ÈÀμö()

±³À°½Ã°£ 04¿ù 20ÀÏ 17:00~17:15 Effective lentigo treatment using VSLS Á¤±Ôµ¿()

±³À°½Ã°£ 04¿ù 20ÀÏ 17:15~17:30 Skin rejuvenation: potential of needle RF in melasma therapy ÃÖõÇÊ()

Åä·Ð 04¿ù 20ÀÏ 17:30~17:40 Q&A ()

±âŸ 04¿ù 20ÀÏ 17:40~17:50 Closing address ()

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦4Â÷ ´ëÇѹé¹ÝÁõ»ö¼ÒÇÐȸ ½ÉÆ÷Áö¾ö : 2024-04-20""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2024 Á¦34Â÷ ´ëÇÑÇ÷¾×ÇÐȸ ¸²ÇÁÁ¾¿¬±¸È¸ Ãá°è½ÉÆ÷Áö¾ö : 2024-04-20
´ÙÀ½±Û Á¦98Â÷ ´ëÇÑÀ̺ñÀÎÈÄ°úÇÐȸ Çмú´ëȸ / 2024³â Ãá°è ´ëÇÑÀ̺ñÀÎÈÄ°úÀÇ»çȸ Çмú´ëȸ in conjunction with International Congress of ORL-HNS 2024(1ÀÏÂ÷) : 2024-04-20
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20559 °æ±â Á¦34Â÷ Áß¾Ó´ëÇб³ ºñ´¢ÀÇÇаú ¿öÅ©¼¥ : 2024-06-01 0 50 2024-04-29
20558 ±¤ÁÖ Á¦2ȸ ´ëÇѺñ¸¸ÇÐȸ È£³²Áöȸ Çмú´ëȸ : 2024-06-01 0 57 2024-04-29
20557 ÀÎõ 2024³â ±èÆ÷½ÃÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-06-01 0 40 2024-04-29
20556 ¼­¿ï 2024 ´ëÇÑ¿ì¿ïÇൿ½Å°æÇבּ¸È¸ Ãá°èÇмú´ëȸ : 2024-06-01 0 39 2024-04-29
20555 ¼­¿ï ´ëÇѽÉÀåÇ÷°üÈäºÎ¿Ü°úÇÐȸ Á¦38Â÷ Ãá°èÅëÇÕÇмú´ëȸ ¹× ¿¬¼ö±³À° (2ÀÏÂ÷) : 2024-06-01 0 27 2024-04-29
20554 ¼­¿ï Á¦ 14Â÷ ´ëÇѸð¹ßÀ̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ(1ÀÏÂ÷) : 2024-06-01 0 31 2024-04-29
20553 ¼­¿ï 2024³â ´ëÇѼҾư¨¿°ÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-31 0 46 2024-04-29
20552 Àü³² ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ È£³²Áöȸ - Á¦297Â÷ ¿ù·ÊÁý´ãȸ : 2024-05-31 0 64 2024-04-29
20551 ¼­¿ï (¿Â¶óÀÎ) 2024 Çѱ¹Á¤½ÅºÐ¼®ÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-31 0 78 2024-04-29
20550 ºÎ»ê Á¦ 169Â÷ ºÎ»êÁö¹æ³²¼º°úÇÐȸ Çмú´ëȸ : 2024-05-31 0 44 2024-04-29
20549 ¼­¿ï ´ëÇѼҾư¨¿°ÇÐȸ Á¦26ȸ ¿¬¼ö°­Á : 2024-05-30 0 40 2024-04-29
20548 °­¿ø 2024³â ¿øÁÖ½ÃÀÇ»çȸ 2Â÷ ¿¬¼ö°­ÁÂ_ÃÖ±Ù ÀÇÇÐÁö°ß : 2024-05-28 0 50 2024-04-29
20547 °æ±â Á¦4ȸ ´ëÇÑ¿Ü°úÇÐȸ ¿Ü°ú³»½Ã°æ ¿¬¼ö°­Á : 2024-05-26 0 54 2024-04-29
20546 ¼­¿ï ´ëÇѺñ´¢ÃÊÀ½ÆÄÇÐȸ Á¦17Â÷ Çмú´ëȸ : 2024-05-26 0 33 2024-04-29
20545 °æºÏ 2024³âµµ °æ»óºÏµµÀÇ»çȸ Á¾ÇÕÇмú´ëȸ(2ÀÏÂ÷) : 2024-05-26 0 60 2024-04-29
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷